Figure 3
Effectiveness at 6 months in PAF patients. (A) Any AF/AFL/AT found on Holter, ECG, or TTM after the blanking period is considered an event. (B) Primary effectiveness endpoint of the study. (C) Symptomatic effectiveness.

Effectiveness at 6 months in PAF patients. (A) Any AF/AFL/AT found on Holter, ECG, or TTM after the blanking period is considered an event. (B) Primary effectiveness endpoint of the study. (C) Symptomatic effectiveness.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close